Cannara Biotech Inc. (TSXV: LOVE)
Canada
· Delayed Price · Currency is CAD 0.670
+0.080 (13.56%)
Nov 20, 2024, 3:46 PM EST
Cannara Biotech Revenue
Cannara Biotech had revenue of 19.54M CAD in the quarter ending May 31, 2024, with 22.64% growth. This brings the company's revenue in the last twelve months to 76.69M, up 50.15% year-over-year. In the fiscal year ending August 31, 2023, Cannara Biotech had annual revenue of 57.26M with 59.76% growth.
Revenue (ttm)
76.69M
Revenue Growth
+50.15%
P/S Ratio
0.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
60.31M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch + Lomb Corporation | 6.33B |
| Bausch Health Companies Inc. | 12.80B |
| Curaleaf Holdings, Inc. | 1.83B |
| dentalcorp Holdings Ltd. | 1.51B |
| Tilray Brands, Inc. | 1.10B |
| Sienna Senior Living Inc. | 867.55M |
| WELL Health Technologies Corp. | 957.69M |
| Cronos Group Inc. | 150.26M |